Please login to the form below

Not currently logged in
Email:
Password:

Cancer Research

This page shows the latest Cancer Research news and features for those working in and with pharma, biotech and healthcare.

Seres’ microbiome-based therapy hits the mark in phase 3

Seres’ microbiome-based therapy hits the mark in phase 3

In March, Seres received funding from AstraZeneca for research expenses associated with a project exploring how the bacteria in the gut can affect, and possibly enhance, the effect of cancer immunotherapies. ... This includes research into Seres’ phase

Latest news

More from news
Approximately 22 fully matching, plus 351 partially matching documents found.

Latest Intelligence

  • A roadmap to the successful treatment of Alzheimer’s disease A roadmap to the successful treatment of Alzheimer’s disease

    Living to tell the tale. Having worked in cancer research 20 years ago, I recall there was often a feeling across the field that we had hit a brick wall and ... To advance Alzheimer’s research, I believe that there are similar lessons to learn from the

  • Building Europe’s next breakthrough biotechs Building Europe’s next breakthrough biotechs

    Its founding investors include Cambridge Innovation Capital, Babraham Research Campus through Babraham Bioscience Technologies, Roche's biotech arm Genentech, and Dr Jonathan Milner and Dr Ian Tomlinson, two of the ... life sciences campus in central

  • 25 Women Leaders in UK Healthcare 25 Women Leaders in UK Healthcare

    using a standard search engine to research health worries can do more harm than good. ... She is also a Women of Influence Mentor for Cancer Research UK and a public governor for The Christie NHS Foundation Trust in Manchester and recently took on the

  • Where next in Alzheimer’s disease R&D? Where next in Alzheimer’s disease R&D?

    The work builds on research at the University of Cambridge that discovered a molecule that reduced the production of Abeta in early-stage tests. ... Yet, as the rapid pace of progress in cancer shows, decades of unsung research into disease biology can

  • Bringing life to precision medicine Bringing life to precision medicine

    Harnessing the power of patient-derived organoids. The global cancer burden. Despite enormous investment over recent decades into research and treatment development, cancer remains one of the leading causes of death ... worldwide, with 18.1 million new

More from intelligence
Approximately 0 fully matching, plus 36 partially matching documents found.

Latest appointments

  • McCann Health France strengthens team with two new hires McCann Health France strengthens team with two new hires

    Initially, she worked on the research and development of new drugs in cardiovascular and metabolic diseases before specialising in oncology and onco-haematology. ... Prior to McCann Health France, she served as scientific director at various

  • F-star hires ex-BMS immuno-oncology leader

    pipeline. As we saw at the recent ASCO meeting, bispecific antibodies are leading a paradigm shift in cancer care and the potential to improve the outcome for cancer patients has never ... He is an active member of the American Society of Clinical

  • Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO

    Under Bahija’s leadership, MedImmune significantly boosted its pipeline, expanding from 40 to more than 130 molecules in research and development targeting cancer; respiratory, inflammation, and autoimmunity; cardiovascular, renal and metabolic;

  • José Baselga joins BMS’ board of directors José Baselga joins BMS’ board of directors

    Dr Baselga is currently the physician in chief at Memorial Sloan Kettering Cancer Center, where he is responsible for the management of patients care, enhancing and expanding programmes in clinical and ... Association for Cancer Research.

  • Glythera strengthens its scientific advisory board and appoints CSO Glythera strengthens its scientific advisory board and appoints CSO

    Dr Lutz was previously vice president of translation research and development at ImmunoGen, where he was responsible for all early-stage ADC development programmes. ... Additionally, Dr Jon Roffey joins Glythera’s scientific advisory board (SAB) from

More from appointments
Approximately 1 fully matching, plus 32 partially matching documents found.

Latest from PMHub

  • July 2020: diversity and inclusion in clinical trials round-up July 2020: diversity and inclusion in clinical trials round-up

    With this in mind, Stand Up To Cancer announced a new $5 million grant from Bristol Myers Squibb to fund research and education efforts to help improve health equality among underserved ... We’re glad to see that Stand Up To Cancer is collaborating

  • Language barriers: Obesity has become a loaded word

    Even the phrase ‘obesity crisis’ is instantly negative. When Cancer Research UK ran their campaign about obesity taking over smoking as the leading cause of cancer,   they were accused of ... by psychological research, and that healthcare

  • World Ovarian Cancer Day: Current treatments and future hopes for ovarian cancer

    4.            Ovarian Cancer Research Alliance. Recurrence. Available at: https://ocrahope.org/patients/about-ovarian-cancer/recurrence/. Accessed April 2019. ... 9.            Committee on the State of the Science in Ovarian

  • International Childhood Cancer Day 2019 International Childhood Cancer Day 2019

    We've pulled together an infographic to show just what we mean with data c/o Cancer Research UK (CRUK) and a great initiative by Beads of Courage, Inc. ... There's still more to do, so show your support for a day when there is No More Pain and No More

  • Maker Projects

    Our clients include: The NHS NWEH Cancer Research Cosentyx / Novartis Brilinta / AstraZeneca Port of Call We have branches in Manchester and London - to find out more: www.makerprojects.co.

More from PMHub
Approximately 1 fully matching, plus 29 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics